# Janssen Pharmaceuticals, Inc – FDA Inspection, Sep 28, 2020

Source: https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/3a8fe62f-7bb7-4a30-a70b-ff5a60a6a59a
Source feed: FDA_Inspections

> FDA inspection 1131617 of Janssen Pharmaceuticals, Inc, September 28, 2020. Classification: No Action Indicated (NAI). 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1131617
- Company Name: Janssen Pharmaceuticals, Inc
- Inspection Date: 2020-09-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1338168 - 2026-09-25](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/16fafd4a-7311-420b-b8bd-7c82af1e2eb7)
- FDA Inspection 1271223 - 2025-08-14
- [FDA Inspection 1229931 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/a957db33-ff2d-4e98-86e3-9332d9d2d54b)
- FDA Inspection 1131381 - 2020-09-14
- FDA Inspection 1031605 - 2017-10-06

Company: https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/7d87f794-c8cc-4a2c-b985-4d62ebc2d60b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c